Evidence map›Paper›PMID 28523535›Full record

ArticleChinese journal of integrative medicine2017

Self-protection against triptolide-induced toxicity in human hepatic cells via Nrf2-ARE-NQO1 pathway.

Ling-Ling Zhou, Cong Zhou, Xiao-Wen Liang, Zhe Feng, Zhang-Pu Liu, Hao-Lu Wang, Xue-Ping Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Cytoprotective Effect ofMolecules (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ling-Ling ZhouSchool of Pharmacy, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Cong ZhouSchool of Pharmacy, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Xiao-Wen LiangTherapeutics Research Centre, School of Medicine, The University of Queensland, Princess Alexandra Hospital, 4102, Woolloongabba, QLD, Australia.
Zhe FengSchool of Pharmacy, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Zhang-Pu LiuSchool of Pharmacy, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Hao-Lu WangTherapeutics Research Centre, School of Medicine, The University of Queensland, Princess Alexandra Hospital, 4102, Woolloongabba, QLD, Australia.
Xue-Ping ZhouSchool of Pharmacy, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China. zxp@njucm.edu.cn.
Nanjing University of Chinese Medicine · CNPrincess Alexandra Hospital · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo find the signaling pathway of triptolide (TP)-induced liver injury and to reveal whether NF-E2-related factor 2 (Nrf2) plays an important role in cellular self-protection.

methodsThe L-02 and HepG2 cells were cultured and treated with various concentrations of TP. The cell viability was observed, and the cell medium was collected for detecting the aspartate aminotransferase (ALT), alanine aminotransferase (AST), lactate dehydrogenase (LDH), superoxide dismutase (SOD) and L-glutathione production (GSH) levels. Nrf2 and its downstream target NAD(P)H: quinine oxidoreductase 1 (NQO1) and heme oxygenase-1 (HO-1) expression, the nuclear translocation of Nrf2, and the binding ability of Nrf2 and antioxidant response element (ARE) were also identified. Meanwhile, shRNA was used to silence Nrf2 in L-02 cells to find out whether Nrf2 plays a protective role.

resultsThe viability of the L-02 and HepG2 cells treated with TP decreased in a doseand time-dependent manner, and TP (20-80 μg/mL) markedly induced the release of ALT, AST and LDH (P<0.05 or P<0.01), reduced the levels of SOD and GSH (P<0.01), and increased the intracellular reactive oxygen species. Meanwhile, TP augmented the Nrf2 expression in L-02 and HepG2 cells (P<0.05 or P<0.01), induced Nrf2 nuclear translocation, increased the Nrf2 ARE binding activity, and increased HO-1 and NQO1 expressions. Nrf2 knockdown revealed a more severe toxic effect of TP (P<0.05 or P<0.01).

conclusionsHuman hepatic cells treated with TP induced oxidative stress, and led to cytotoxicity. Self-protection against TP-induced toxicity in human hepatic cells might be via Nrf2-ARE-NQO1 transcriptional pathway.

Indexed as

Antioxidant Response ElementsCell DeathCell NucleusCytoprotectionDiterpenesEpoxy CompoundsGene Knockdown TechniquesHeme Oxygenase-1HepatocytesHep G2 CellsHumansNAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2Oxidative StressPhenanthrenesRNA, Small InterferingDiterpenesEpoxy CompoundsHeme Oxygenase-1NAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2NQO1 protein, humanPhenanthrenesRNA, Small Interferingtriptolideliver injuryNF-E2-related factor 2oxidative stresstriptolide, human hepatic cells

Identifiers

PMID28523535
OpenAlexW2614425307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.